Moreover, as a consequence of the AKT activation, NEAT1v1 sensitizes liver cancer cell lines to an AKT-targeted drug, capivasertib, suggesting that NEAT1v1 induces AKT addiction [25]. This evidence concerns the gene AKT1 and liver cancer.